Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CASSAVA-SCIENCES-INC-56537199/news/Cassava-Sciences-Completes-Enrollment-for-Pivotal-Phase-3-Program-of-Simufilam-in-Alzheimer-S-Diseas-45253071/?utm_source=whatsapp&utm_medium=social&utm_campaign=share